2m 2m 2m 2m 2m 2m 2m
GENELUX (GNLX)
NASDAQ
$2.56+$0.07 (+2.65%)
Price as of Sep 11, 2026 7:30 PM EDT- $112.7MMarket Cap
- -36.96%1-Year Change
- BiotechnologyIndustry
GENELUX (GNLX)
$2.56+$0.07 (+2.65%)
GNLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.49 | ||
Change | +$0.01 (+0.40%) | ||
Open | $2.53 | ||
High | $2.55 | ||
Low | $2.45 | ||
Previous Close | $2.48 | ||
Volume | 146,907 | ||
30-Day Average Volume | 333,619 | ||
1-Week Change | 2.05% | ||
1-Month Change | -6.04% | ||
1-Year Change | -36.96% | ||
3-Year Change | -88.88% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.2M | ||
Total Assets | $26.2M | ||
Market Cap | $112.7M | ||
Enterprise Value | $103.5M | ||
Period: QTR TTM FY | |||
Revenue | $3,000.00 | ||
Net Income | -$9.5M | ||
Free Cash Flow | -$8.0M | ||
EBIT | -$9.5M | ||
EBITDA | -$9.5M | ||
Net Working Capital | $11.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 34,492 | ||
P/B | 7 | ||
P/E | -12 | ||
PEG | 2 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue